Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Winterbottom

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|November 14, 2015
Imaging After Nellix Endovascular Aneurysm Sealing: A Consensus DocumentAndrew Holden, Janis Savlovskis, Andrew Winterbottom, et al.
European Urology|July 22, 2014
European Association of Urology (@Uroweb) recommendations on the appropriate use of social mediaMorgan Rouprêt, Todd M Morgan, Peter J Bostrom, et al.
Lancet (London, England)|March 9, 2020
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trialAlison Birtle, Mark Johnson, John Chester, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|November 14, 2015
Imaging After Nellix Endovascular Aneurysm Sealing: A Consensus DocumentAndrew Holden, Janis Savlovskis, Andrew Winterbottom, et al.
European Urology|July 22, 2014
European Association of Urology (@Uroweb) recommendations on the appropriate use of social mediaMorgan Rouprêt, Todd M Morgan, Peter J Bostrom, et al.
Lancet (London, England)|March 9, 2020
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trialAlison Birtle, Mark Johnson, John Chester, et al.
Pageof 3